Humira patent strategy makes the case for reform – Crain’s Chicago Business

Humira patent strategy makes the case for reform  Crain’s Chicago Business

AbbVie has twisted U.S. patent law far beyond its fundamental purpose of spurring innovation by giving inventors an opportunity to reap a return on their …